ABL Bio Inc. (KOSDAQ:298380)
South Korea · Delayed Price · Currency is KRW 213,000
+2,500 (1.19%)
Jan 8, 2026, 1:20 PM KST
ABL Bio Market Cap
ABL Bio has a market cap or net worth of 11.6 trillion as of January 7, 2026. Its market cap has increased by 734.50% in one year.
Market Cap
11.60T
Enterprise Value
11.52T
Revenue
88.44B
Ranking
n/a
PE Ratio
n/a
Stock Price
213,000.00
Market Cap Chart
Since December 19, 2018, ABL Bio's market cap has increased from 608.61B to 11.60T, an increase of 1,806.61%. That is a compound annual growth rate of 51.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 7, 2026 | 11.60T | 5.25% |
| Dec 30, 2025 | 11.03T | 663.70% |
| Dec 30, 2024 | 1.44T | 22.53% |
| Dec 28, 2023 | 1.18T | 7.19% |
| Dec 29, 2022 | 1.10T | 5.54% |
| Dec 30, 2021 | 1.04T | -27.59% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 79.30T |
| Celltrion | 45.84T |
| ALTEOGEN | 25.06T |
| SK Biopharmaceuticals | 9.87T |
| Yuhan | 8.55T |
| HLB Co., Ltd. | 7.09T |
| LigaChem Biosciences | 6.41T |
| Peptron | 6.02T |